Cross presentation of tumor antigens tumors antigen of tumor. Medical search. Frequent questions

Home page Questions and answers Statistics Donations Contact

Anatomy23

Dendritic Cells Endosomes Cell Line, Tumor Cell Line T-Lymphocytes T-Lymphocytes, Cytotoxic CD8-Positive T-Lymphocytes Cells, Cultured Lymphocytes, Tumor-Infiltrating CD4-Positive T-Lymphocytes Antigen-Presenting Cells Clone Cells Spleen Lymph Nodes B-Lymphocytes Tumor Cells, Cultured Cell Line, Transformed Lymphocytes Immune Sera Macrophages Hybridomas Fibroblasts Killer Cells, Natural

Organisms12

Simian virus 40 Mice, Inbred BALB C Mice, Inbred C57BL Mice, Transgenic Polyomavirus Polyomaviridae Mice, SCID Mice, Nude Mice, Inbred Strains Adenoviridae Mice, Knockout Rats, Inbred F344

Diseases53

Neoplasms, Experimental Wilms Tumor Neoplasms Carcinoid Tumor Brain Neoplasms Melanoma, Experimental Mammary Neoplasms, Experimental Neuroendocrine Tumors Adenocarcinoma Cell Transformation, Neoplastic Fibrosarcoma Sarcoma, Experimental Neoplasm Metastasis Colonic Neoplasms Neovascularization, Pathologic Ovarian Neoplasms Skin Neoplasms Melanoma Kidney Neoplasms Liver Neoplasms Gastrointestinal Stromal Tumors Cell Transformation, Viral Glioma Pancreatic Neoplasms Disease Progression Breast Neoplasms Carcinoma, Squamous Cell Disease Models, Animal Carcinoma, Ehrlich Tumor Lymphoma Glioblastoma Tumor Virus Infections Lung Neoplasms Rhabdoid Tumor Carcinoma, Hepatocellular Granulosa Cell Tumor Neoplasm Recurrence, Local Bone Neoplasms Mammary Neoplasms, Animal Carcinoma, Renal Cell Urinary Bladder Neoplasms Phyllodes Tumor Liver Neoplasms, Experimental Astrocytoma Lymphatic Metastasis Neuroblastoma Glomus Tumor Neuroectodermal Tumors, Primitive Gastrointestinal Neoplasms Stomach Neoplasms Adenoma Giant Cell Tumor of Bone Meningioma

Chemicals and Drugs88

Scavenger Receptors, Class F Antigens, Neoplasm Antigens, Viral, Tumor Antigens Histocompatibility Antigens Class I Antigens, Polyomavirus Transforming Antigens, Bacterial Antigens, Surface Antigens, Viral Tumor Markers, Biological Cancer Vaccines Tumor Necrosis Factor-alpha Antibodies, Monoclonal Tumor Suppressor Protein p53 Neoplasm Proteins HLA-A2 Antigen Carcinoembryonic Antigen Epitopes HLA Antigens Antigens, Protozoan MART-1 Antigen H-2 Antigens Tumor Suppressor Proteins Antigens, CD RNA, Messenger Antigens, Tumor-Associated, Carbohydrate Histocompatibility Antigens Class II Antibodies, Neoplasm gp100 Melanoma Antigen Receptors, Antigen, T-Cell HLA-A Antigens Antigens, Fungal Melanoma-Specific Antigens HLA-DR Antigens Antigens, Helminth Interferon-gamma Histocompatibility Antigens Epitopes, T-Lymphocyte Proliferating Cell Nuclear Antigen Immunoglobulin G Mucin-1 Peptides Prostate-Specific Antigen Recombinant Proteins DNA, Neoplasm Antigens, CD8 Peptide Fragments Antigens, CD80 Receptors, Antigen, B-Cell Antigens, CD3 Recombinant Fusion Proteins Cytokines Antibodies Ovalbumin Membrane Proteins O Antigens Antigens, CD15 Ki-67 Antigen Antigens, CD40 Receptors, Antigen Antigens, Differentiation DNA, Viral HLA-A1 Antigen Adjuvants, Immunologic DNA-Binding Proteins RNA, Neoplasm Autoantigens Immune Sera Antigen-Antibody Complex Glycoproteins Hepatitis B Surface Antigens HLA-D Antigens Blood Group Antigens DNA Primers Oncogene Proteins, Viral Antineoplastic Agents Receptors, Tumor Necrosis Factor, Type I Interleukin-2 HLA-A3 Antigen Antigens, CD45 Antigens, CD1 Antigens, CD4 Antigens, CD86 DNA Vaccines, DNA Methylcholanthrene Transcription Factors Proto-Oncogene Proteins

Analytical, Diagnostic and Therapeutic Techniques and Equipment42

Neoplasms, Experimental Tumor Burden Immunotherapy Melanoma, Experimental Mammary Neoplasms, Experimental Lymphocyte Activation Sarcoma, Experimental Flow Cytometry Enzyme-Linked Immunosorbent Assay Immunotherapy, Adoptive Transfection Transplantation, Heterologous Neoplasm Transplantation Immunohistochemistry Reverse Transcriptase Polymerase Chain Reaction Immunoenzyme Techniques Immunization Xenograft Model Antitumor Assays Blotting, Western Fluorescent Antibody Technique Neoplasm Staging Treatment Outcome Disease Models, Animal Polymerase Chain Reaction Sensitivity and Specificity Immunotherapy, Active Retrospective Studies Combined Modality Therapy Genetic Therapy Gene Expression Profiling Tomography, X-Ray Computed Vaccination Cytotoxicity Tests, Immunologic Survival Analysis Cloning, Molecular Magnetic Resonance Imaging Liver Neoplasms, Experimental Tumor Stem Cell Assay Prognosis Models, Biological Immunoblotting Survival Rate

Phenomena and Processes43

Cross-Priming Antigen Presentation Genes, Tumor Suppressor Lymphocyte Activation Tumor Microenvironment Cytotoxicity, Immunologic Amino Acid Sequence Base Sequence Cell Proliferation Cell Division Time Factors Transfection Mutation Cross Reactions Antibody Specificity Signal Transduction Cell Transformation, Viral Immunity, Cellular Phenotype Genetic Vectors Gene Expression Regulation, Neoplastic Gene Expression Antibody Formation Molecular Weight Sensitivity and Specificity Antigen-Antibody Reactions Cell Survival Cell Movement Tissue Distribution Protein Binding Cell Differentiation Immune Tolerance Dose-Response Relationship, Drug Promoter Regions, Genetic Apoptosis Down-Regulation Transcription, Genetic Up-Regulation Gene Expression Regulation Tumor Escape Plasmids Phosphorylation Major Histocompatibility Complex

Disciplines and Occupations1

Immunohistochemistry

Information Science4

Molecular Sequence Data Amino Acid Sequence Base Sequence Survival Rate

Health Care7

Immunization Treatment Outcome Sensitivity and Specificity Retrospective Studies Vaccination Survival Analysis Survival Rate

Anatomy Organisms Diseases Chemicals and Drugs Analytical, Diagnostic and Therapeutic Techniques and Equipment Phenomena and Processes Disciplines and Occupations Information Science Health Care

Scavenger Receptors, Class F Cross-Priming Antigens, Neoplasm Antigen Presentation Antigens, Viral, Tumor Antigens Dendritic Cells Histocompatibility Antigens Class I Antigens, Polyomavirus Transforming Endosomes Antigens, Bacterial Antigens, Surface Antigens, Viral Tumor Markers, Biological Cell Line, Tumor Cancer Vaccines Tumor Necrosis Factor-alpha Simian virus 40 Neoplasms, Experimental Tumor Burden Mice, Inbred BALB C Antibodies, Monoclonal Mice, Inbred C57BL Wilms Tumor Tumor Suppressor Protein p53 Neoplasm Proteins Cell Line HLA-A2 Antigen Immunotherapy Carcinoembryonic Antigen T-Lymphocytes Neoplasms Genes, Tumor Suppressor Molecular Sequence Data Carcinoid Tumor Epitopes T-Lymphocytes, Cytotoxic HLA Antigens Brain Neoplasms Melanoma, Experimental Mammary Neoplasms, Experimental Antigens, Protozoan Lymphocyte Activation Tumor Microenvironment MART-1 Antigen CD8-Positive T-Lymphocytes Neuroendocrine Tumors H-2 Antigens Mice, Transgenic Adenocarcinoma Tumor Suppressor Proteins Cytotoxicity, Immunologic Amino Acid Sequence Antigens, CD Cell Transformation, Neoplastic Fibrosarcoma Sarcoma, Experimental Polyomavirus RNA, Messenger Neoplasm Metastasis Base Sequence Flow Cytometry Antigens, Tumor-Associated, Carbohydrate Cell Proliferation Histocompatibility Antigens Class II Enzyme-Linked Immunosorbent Assay Cell Division Immunotherapy, Adoptive Antibodies, Neoplasm Colonic Neoplasms gp100 Melanoma Antigen Time Factors Receptors, Antigen, T-Cell HLA-A Antigens Transfection Antigens, Fungal Cells, Cultured Transplantation, Heterologous Melanoma-Specific Antigens HLA-DR Antigens Neovascularization, Pathologic Mutation Antigens, Helminth Ovarian Neoplasms Skin Neoplasms Cross Reactions Interferon-gamma Melanoma Neoplasm Transplantation Polyomaviridae Histocompatibility Antigens Immunohistochemistry Reverse Transcriptase Polymerase Chain Reaction Immunoenzyme Techniques Kidney Neoplasms Immunization Xenograft Model Antitumor Assays Antibody Specificity Lymphocytes, Tumor-Infiltrating Liver Neoplasms

No FAQ available that match "cross presentation of tumor antigens tumors antigen of tumor"